Tatsuya Morimoto

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan

Articles by Tatsuya Morimoto

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases

Kana Shimizu, Masafumi Funamoto, Yoichi Sunagawa, et al

Citation: European Cardiology Review 2019;14(2):117–22

DOI:

https://doi.org/10.15420/ecr.2019.17.2
Erratum to: The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine- Induced Responses in Cardiomyocytes

Mai Genpei, Yoichi Sunagawa, Masafumi Funamoto, et al

Citation: European Cardiology Review 2018;13(2):136.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.ER1
Analysis of the Effects of EPA and DHA on Cardiomyocyte hypertrophy

Ayumi Katayama, Masafumi Funamoto, Kana Shimizu, et al

Citation: European Cardiology Review 2018;13(2):121.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO2
The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy

Satoshi Shimizu, Yoichi Sunagawa, Kodai Hara, et al

Citation: European Cardiology Review 2018;13(2):125.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO6
TBL1 Suppresses Cardiomyocyte Hypertrophy by Regulating the Interaction Between HDAC3 and GATA4

Yasufumi Katanasaka, Masatoshi Namiki, Yoichi Sunagawa, et al

Citation: European Cardiology Review 2018;13(2):126.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO7
A PRMT5 Selective Inhibitor EPZ015666 Suppressed TAC-induced Left Ventricular Dysfunction

Kazuma Hanajima, Yusuke Miyazaki, Yasufumi Katanasaka, et al

Citation: European Cardiology Review 2018;13(2):130.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO11
Nobiletin a Citrus Flavonoid, Exerts Additional Effects with Angiotensin II Receptor Blocker on Systolic Function in Salt-sensitive Dahl Rats

Haruka Ebi, Masafumi Funamoto, Yoichi Sunagawa, et al

Citation: European Cardiology Review 2017;12(2):92.

DOI:

https://doi.org/10.15420/ecr.2017:23:1
Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Maki Komiyama, Hiromichi Wada, Hajime Yamakage, et al

Citation: European Cardiology Review 2017;12(2):96.

DOI:

https://doi.org/10.15420/ecr.2017:23:5
A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure

Masafumi Funamoto, Yoichi Sunagawa, Yasufumi Katanasaka, et al

Citation: European Cardiology Review 2017;12(2):110.

DOI:

https://doi.org/10.15420/ecr.2017:23:19